Introduction: A reliable peptide purity testing report should provide a complete analytical overview that confirms peptide identity, purity, composition, and […]
Common Reasons Biosimilars Fail Analytical Comparability (and How to Fix Them) Read More »
Introduction: Why Critical Quality Attributes (CQAs) in Biosimilars Need Advanced Analysis The evaluation of Critical Quality Attributes (CQAs) in Biosimilars
Comparative Analytical Framework for PLGA Systems PLGA Implant vs Microsphere Characterization focuses on understanding how PLGA polymer structure affects the
Introduction: Why E&L Testing for Pre-Filled Syringes Requires a Specialized Strategy E&L Testing for Pre-Filled Syringes is much more complex
Introduction: Biosimilar Comparability Studies use an advanced fingerprinting strategy to prove that a follow-on biologic is highly similar to its
Biosimilar Comparability Studies: Mass Spectrometry-Based Fingerprinting Approach Read More »
Introduction: The Analytical Importance of Impurity Profiling of Biosimilars Impurity Profiling of Biosimilars is one of the most important steps
Why is Charge Variant Analysis in Biosimilars Important for Regulatory Approval? Charge Variant Analysis in Biosimilars is an essential part
Charge Variant Analysis in Biosimilars: Mass Spectrometry Approaches for Heterogeneity Read More »
Introduction: Why Disulfide Bond Mapping in Biosimilars Matters Disulfide Bond Mapping in Biosimilars is a critical part of biosimilar characterization
Disulfide Bond Mapping in Biosimilars: Ensuring Structural Integrity Using LC-MS Read More »
The Strategic Role of Forced Degradation of Biosimilars in Development Forced Degradation of Biosimilars is an essential analytical approach used
Deamidation and Oxidation in Biosimilars: Forced Degradation and LC-MS Mapping Read More »
Introduction: Why Site-Specificity Is the Defining Challenge in Glycosylation Analysis of Biosimilars Glycosylation Analysis of Biosimilars is a critical step
